Is Irhythm Technologies Inc (IRTC) Stock About to Get Hot Thursday?

Irhythm Technologies Inc (IRTC) stock is up 37.68% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Irhythm Technologies Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on IRTC!

See Full IRTC Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With IRTC Stock Today?

Irhythm Technologies Inc (IRTC) stock is trading at $144.03 as of 10:32 AM on Thursday, Jan 13, a gain of $1.64, or 1.15% from the previous closing price of $142.39. The stock has traded between $142.67 and $147.89 so far today. Volume today is low. So far 92,089 shares have traded compared to average volume of 492,632 shares. To screen for more stocks like Irhythm Technologies Inc click here.

More About Irhythm Technologies Inc

iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company derived its revenue from the United States. Click Here to get the full Stock Report for Irhythm Technologies Inc stock.